HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

N- 1- (hydroxy(3- oxo- 2- phenyl- 1- cyclopropen- 1- yl)methyl)- 2- methylpropyl- 2- benzenesulfonylamino- 4- methylpentanamide

Also Known As:

BDA-410

Networked: 5 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Amides: 2428
  - Sulfonamides: 2809
    - N-1-(hydroxy(3-oxo-2-phenyl-1-cyclopropen-1-yl)methyl)-2-methylpropyl-2-benzenesulfonylamino-4-methylpentanamide: 5
- Sulfur Compounds: 278
  - Sulfones: 534
    - Sulfonamides: 2809
      - N-1-(hydroxy(3-oxo-2-phenyl-1-cyclopropen-1-yl)methyl)-2-methylpropyl-2-benzenesulfonylamino-4-methylpentanamide: 5

Experts

1.	Chishti, Athar H: 3 articles (02/2013 - 09/2007)
2.	Balakrishnan, Anju: 2 articles (01/2013 - 01/2012)
3.	Howatt, Deborah A: 2 articles (01/2013 - 01/2012)
4.	Moorleghen, Jessica J: 2 articles (01/2013 - 01/2012)
5.	Subramanian, Venkateswaran: 2 articles (01/2013 - 01/2012)
6.	Uchida, Haruhito A: 2 articles (01/2013 - 01/2012)
7.	Abba, Martin C: 1 article (08/2017)
8.	Delbono, Osvaldo: 1 article (08/2017)
9.	Devarie-Baez, Nelmi O: 1 article (08/2017)
10.	Files, Daniel Clark: 1 article (08/2017)

Related Diseases

1.	Atherosclerosis 01/01/2012 - "We conclude that calpain inhibition using BDA-410 attenuated AngII-induced AAA formation and atherosclerosis development in low-density lipoprotein receptor-/- mice."
2.	Malaria 09/01/2007 - "BDA-410 inhibited the malaria parasite growth in vitro with an IC(50) value of 173nM causing irreversible damage to the intracellular parasite. " 09/01/2007 - "In vivo, the BDA-410 delayed the progression of malaria infection significantly using a mouse model of malaria pathogenesis. " 09/01/2007 - "The effect of BDA-410 on the malaria parasite development in vitro as well as its anti-malarial activity in vivo was evaluated using the Plasmodium chabaudi infection rodent model. "
3.	Infections 09/01/2007 - "In vivo, the BDA-410 delayed the progression of malaria infection significantly using a mouse model of malaria pathogenesis. " 09/01/2007 - "The effect of BDA-410 on the malaria parasite development in vitro as well as its anti-malarial activity in vivo was evaluated using the Plasmodium chabaudi infection rodent model. "
4.	Hypertrophy 01/01/2013 - "Furthermore, BDA-410 administration attenuated AngII-induced aortic medial hypertrophy and macrophage accumulation. "
5.	Dehydration (Water Stress) 02/01/2013 - "BDA-410 prevented hypoxia-induced RBC dehydration and K(+) loss in SAD mice. "

Related Drugs and Biologics

1.	LDL Receptors (LDL Receptor)
2.	Proteins (Proteins, Gene)
3.	Calpain
4.	Antimalarials (Antimalarial Agents)
5.	calpain inhibitors